235 related articles for article (PubMed ID: 17537851)
1. Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.
Guerra S; Nájera JL; González JM; López-Fernández LA; Climent N; Gatell JM; Gallart T; Esteban M
J Virol; 2007 Aug; 81(16):8707-21. PubMed ID: 17537851
[TBL] [Abstract][Full Text] [Related]
2. Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells.
Guerra S; López-Fernández LA; Pascual-Montano A; Nájera JL; Zaballos A; Esteban M
J Virol; 2006 Jan; 80(2):985-98. PubMed ID: 16379000
[TBL] [Abstract][Full Text] [Related]
3. Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.
Nájera JL; Gómez CE; Domingo-Gil E; Gherardi MM; Esteban M
J Virol; 2006 Jun; 80(12):6033-47. PubMed ID: 16731942
[TBL] [Abstract][Full Text] [Related]
4. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
Gómez CE; Nájera JL; Jiménez EP; Jiménez V; Wagner R; Graf M; Frachette MJ; Liljeström P; Pantaleo G; Esteban M
Vaccine; 2007 Apr; 25(15):2863-85. PubMed ID: 17113200
[TBL] [Abstract][Full Text] [Related]
5. Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells.
Guerra S; López-Fernández LA; Conde R; Pascual-Montano A; Harshman K; Esteban M
J Virol; 2004 Jun; 78(11):5820-34. PubMed ID: 15140980
[TBL] [Abstract][Full Text] [Related]
6. Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS.
Guerra S; González JM; Climent N; Reyburn H; López-Fernández LA; Nájera JL; Gómez CE; García F; Gatell JM; Gallart T; Esteban M
J Virol; 2010 Aug; 84(16):8141-52. PubMed ID: 20534857
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.
Delaloye J; Filali-Mouhim A; Cameron MJ; Haddad EK; Harari A; Goulet JP; Gomez CE; Perdiguero B; Esteban M; Pantaleo G; Roger T; Sékaly RP; Calandra T
J Virol; 2015 Apr; 89(7):3819-32. PubMed ID: 25609807
[TBL] [Abstract][Full Text] [Related]
8. Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.
Ludwig H; Mages J; Staib C; Lehmann MH; Lang R; Sutter G
J Virol; 2005 Feb; 79(4):2584-96. PubMed ID: 15681458
[TBL] [Abstract][Full Text] [Related]
9. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
10. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
[TBL] [Abstract][Full Text] [Related]
11. Activation of human dendritic cells by recombinant modified vaccinia virus Ankara vectors encoding survivin and IL-2 genes in vitro.
Tao R; Li L; Huang W; Zheng L
Hum Gene Ther; 2010 Jan; 21(1):98-108. PubMed ID: 19715401
[TBL] [Abstract][Full Text] [Related]
12. Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity.
Kastenmuller W; Drexler I; Ludwig H; Erfle V; Peschel C; Bernhard H; Sutter G
Virology; 2006 Jul; 350(2):276-88. PubMed ID: 16595141
[TBL] [Abstract][Full Text] [Related]
13. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
Waibler Z; Anzaghe M; Ludwig H; Akira S; Weiss S; Sutter G; Kalinke U
J Virol; 2007 Nov; 81(22):12102-10. PubMed ID: 17855554
[TBL] [Abstract][Full Text] [Related]
14. Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect.
Brandler S; Lepelley A; Desdouits M; Guivel-Benhassine F; Ceccaldi PE; Lévy Y; Schwartz O; Moris A
J Virol; 2010 May; 84(10):5314-28. PubMed ID: 20219934
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.
Climent N; Guerra S; García F; Rovira C; Miralles L; Gómez CE; Piqué N; Gil C; Gatell JM; Esteban M; Gallart T
PLoS One; 2011; 6(5):e19644. PubMed ID: 21625608
[TBL] [Abstract][Full Text] [Related]
16. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
Paoletti E; Taylor J; Meignier B; Meric C; Tartaglia J
Dev Biol Stand; 1995; 84():159-63. PubMed ID: 7796949
[TBL] [Abstract][Full Text] [Related]
17. Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens.
Gómez CE; Nájera JL; Sánchez R; Jiménez V; Esteban M
Vaccine; 2009 May; 27(24):3165-74. PubMed ID: 19446187
[TBL] [Abstract][Full Text] [Related]
18. Uptake of antigens from modified vaccinia Ankara virus-infected leukocytes enhances the immunostimulatory capacity of dendritic cells.
Flechsig C; Suezer Y; Kapp M; Tan SM; Löffler J; Sutter G; Einsele H; Grigoleit GU
Cytotherapy; 2011 Jul; 13(6):739-52. PubMed ID: 21250864
[TBL] [Abstract][Full Text] [Related]
19. Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.
Chahroudi A; Garber DA; Reeves P; Liu L; Kalman D; Feinberg MB
J Virol; 2006 Sep; 80(17):8469-81. PubMed ID: 16912297
[TBL] [Abstract][Full Text] [Related]
20. Attenuated poxvirus vectors MVA and NYVAC as promising vaccine candidates against HIV/AIDS.
Esteban M
Hum Vaccin; 2009 Dec; 5(12):867-71. PubMed ID: 19786840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
